Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
3.680
+0.040 (1.10%)
At close: Jun 6, 2025, 4:00 PM
3.700
+0.020 (0.55%)
After-hours: Jun 6, 2025, 7:58 PM EDT
Ardelyx Employees
Ardelyx had 395 employees as of December 31, 2024. The number of employees increased by 128 or 47.94% compared to the previous year.
Employees
395
Change (1Y)
128
Growth (1Y)
47.94%
Revenue / Employee
$915,711
Profits / Employee
-$136,106
Market Cap
880.46M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
ARDX News
- 5 days ago - Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer - GlobeNewsWire
- 17 days ago - Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025 - GlobeNewsWire
- 4 weeks ago - Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference - GlobeNewsWire
- 5 weeks ago - Ardelyx: Revenue Misses And Losses Widen Amid XPHOZAH Uncertainty - Seeking Alpha
- 5 weeks ago - Ardelyx, Inc. (ARDX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors - GlobeNewsWire
- 6 weeks ago - Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference - GlobeNewsWire